Call for Abstract

5th International Conference on Brain Disorders and Therapeutics, will be organized around the theme “Rethinking the Brain: Spread Your Intellectual Insight in Comprehending Brain Disorders”

Brain Disorders 2017 is comprised of 20 tracks and 131 sessions designed to offer comprehensive sessions that address current issues in Brain Disorders 2017.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Brain Networks
  • Track 1-2Cerebrum, Cerebellum & brain stem
  • Track 1-3Neurogenesis of brain development
  • Track 1-4Structural and Functional Neuroimaging
  • Track 2-1Drugs and the Brain
  • Track 2-2Drugs, Brain and Behavior
  • Track 2-3Substance Absue
  • Track 2-4Addiction and Brain Chemistry
  • Track 2-5Addictive Brain Recovery
  • Track 2-6Addiction and the Brains Pleasure Pathway
  • Track 3-1Neonatal Neurology
  • Track 3-2Neuro developmental disorders
  • Track 3-3Pediatric Neurosurgery
  • Track 3-4Pediatric Endocrinology
  • Track 3-5Pediatric Cancer and Brain Disorders
  • Track 3-6Pediatric Mental Health and Psychiatry
  • Track 4-1Neuro Immune Pharmacology
  • Track 4-2Behavioral Neuropharmacology
  • Track 4-3Neurochemical Transmission
  • Track 4-4NeuroPharmacotherapy and Pharmacotherapeutics
  • Track 5-1Neurogenesis and stem cell transplants
  • Track 5-2Pharmaceuticals: Brain power
  • Track 5-3Therapeutic brain stimulation
  • Track 5-4Tau-Based Treatment Strategies
  • Track 5-5Anti-amyloid therapy
  • Track 5-6Comprehensive treatment
  • Track 5-7Future research directions in brain disorders
  • Track 6-1Animals Models for Brain Disorders
  • Track 6-2Animal models of traumatic brain injury
  • Track 6-3Animal models of neurobehavioral disorders
  • Track 6-4Animal Models of Brain Tumors
  • Track 6-5Animal models of ischemic stroke
  • Track 6-6Neuroimaging of animal models
  • Track 6-7Deep brain stimulation
  • Track 6-8Ethical Considerations and Alternatives
  • Track 7-1Systems Neuroscience
  • Track 7-2Neuromorphic engineering
  • Track 7-3Brain Stimulation
  • Track 7-4NeuroModulation
  • Track 7-5Advanced Modelling and Mechanisms
  • Track 7-6Experimental Design for Neuroimaging
  • Track 7-7Data Acquisition in Neuroimaging
  • Track 8-1Brain Mapping
  • Track 8-2Neuro-Informatics
  • Track 8-3Current trends in Neuroinformatics
  • Track 8-4Neural Networks and Genetic Algorithms
  • Track 8-5Brain-Computer Interfaces
  • Track 8-6Neuro Sensing and Neural Prosthesis
  • Track 8-7Controlling Neurons, Circuits and Behavior
  • Track 9-1Advance Practice Nursing
  • Track 9-2Geriatric Nursing
  • Track 9-3Pediatrics Nursing
  • Track 9-4Neurocritical Care
  • Track 9-5Clinical nursing
  • Track 9-6Neurosurgical Nursing
  • Track 9-7Psychiatric and mental health nursing
  • Track 10-1Psychiatry
  • Track 10-2Psychotherapy
  • Track 10-3Psychopathology
  • Track 10-4Neuropsychiatry
  • Track 10-5Neuropsychoimmunology
  • Track 11-1Cerebro spinal disorders
  • Track 11-2Neuropathology of CSF
  • Track 11-3CSF Complications
  • Track 11-4Cognitive Disorders
  • Track 11-5Pseudotumor Cerebri
  • Track 11-6CNS infections
  • Track 11-7Cerebro Spinal Fluid Analysis
  • Track 12-1Aging and Neurodegeneration
  • Track 12-2Alzheimer Disease and Dementia
  • Track 12-3Parkinson’s disease and Movement disorders
  • Track 12-4Huntington disease
  • Track 12-5Amyotrophic lateral sclerosis
  • Track 12-6Motor neurone diseases
  • Track 12-7Spinocerebellar ataxia
  • Track 12-8Spinal muscular atrophy
  • Track 12-9Lewy body disease
  • Track 13-1Migraine and Headache Symptoms
  • Track 13-2Primary and secondary headaches
  • Track 13-3Migraine and Headache: Causes and Treatments
  • Track 13-4Non-migraine headaches
  • Track 13-5Migraine: Multiple processes, complex pathophysiology
  • Track 13-6Migraine and the risk of stroke
  • Track 13-7New Approaches towards Migraine treatment
  • Track 14-1Neuroimmunology
  • Track 14-2Neurovirology
  • Track 14-3Neuro-immune pathology
  • Track 14-4Neuro-immune Interaction
  • Track 14-5Neuropharmacology and Therapeutics
  • Track 14-6Neuropeptides and Neurohormones
  • Track 14-7Neurobiology of Brain Disorders
  • Track 14-8Neurolinguistics and Neuroheuristics
  • Track 15-1Seizures/Epilepsy
  • Track 15-2Multiple sclerosis
  • Track 15-3Autism and Schizophrenia
  • Track 15-4Sleep disorders
  • Track 15-5Neurodegenerative Diseases
  • Track 15-6Brain Tumors
  • Track 15-7Traumatic brain injury
  • Track 15-8Hyperactivity disorder and Peripheral Neuropathy
  • Track 15-9Anxiety, Stress and Depression
  • Track 15-10Bipolar Disorders
  • Track 16-1Chronic villus sampling
  • Track 16-2Pre-symptomatic testing
  • Track 16-3Biomarkers
  • Track 16-4Molecular diagnostics
  • Track 16-5Neuroimaging
  • Track 17-1General and Functional Neurosurgery
  • Track 17-2Spinal Surgery
  • Track 17-3Cerebrovascular surgery
  • Track 17-4Vascular neurosurgery
  • Track 17-5Neurosurgical Oncology
  • Track 18-1Molecular and cellular mechanisms
  • Track 18-2Altered cerebral hemodynamics
  • Track 18-3Cerebrovascular autoregulation
  • Track 18-4Cerebral oxygenation
  • Track 18-5Excitotoxic cell damage
  • Track 18-6Inflammation
  • Track 18-7Cerebral metabolic dysfunction
  • Track 18-8Impaired Cognitive Function
  • Track 19-1Brain trauma
  • Track 19-2Stroke & other vascular diseases
  • Track 19-3Infections
  • Track 19-4Tumors
  • Track 19-5Mental disorders
  • Track 19-6Brain injuries
  • Track 20-1Biofeedback Therapy: Uses and Benefits
  • Track 20-2Types, Purpose and Risks
  • Track 20-3Biofeedback Equipment/Devices
  • Track 20-4Development of Biofeedback Therapy
  • Track 20-5Conditions treated using Biofeedback